| Autor: |
Khalid O. Alfarouk, Adil H. H. Bashir, Ahmed N. Aljarbou, AbdelRahman M. Ramadan, Abdel Khalig Muddathir, Sari T. S. AlHoufie, Abdelhamid Hifny, Gamal O. Elhassan, Muntaser E. Ibrahim, Saad S. Alqahtani, Shakir D. AlSharari, Claudiu T. Supuran, Cyril Rauch, Rosa Angela Cardone, Stephan J. Reshkin, Stefano Fais, Salvador Harguindey |
| Jazyk: |
angličtina |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Frontiers in Oncology, Vol 9 (2019) |
| Druh dokumentu: |
article |
| ISSN: |
2234-943X |
| DOI: |
10.3389/fonc.2019.00075 |
| Popis: |
Helicobacter pylori (HP) is a facultative anaerobic bacterium. HP is a normal flora having immuno-modulating properties. This bacterium is an example of a microorganism inducing gastric cancer. Its carcinogenicity depends on bacteria-host related factors. The proper understanding of the biology of HP inducing gastric cancer offers the potential strategy in the managing of HP rather than eradicating it. In this article, we try to summarize the biology of HP-induced gastric cancer and discuss the current pharmacological approach to treat and prevent its carcinogenicity. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
